Skip to main content
. 2021 Apr 30;9:665161. doi: 10.3389/fcell.2021.665161

FIGURE 3.

FIGURE 3

Prognostic validation in PACA-CA and Ruijin cohorts. (A,B) Distribution of risk score and survival status in PACA-CA and Ruijin cohorts, respectively. (C,D) K-M survival curves estimating DFS difference in two cohorts. (E,F) ROC curves of risk signature and clinical indicators in two cohorts.